As complications of SCD follow from polymerisation of HbS and RBC sickling, there has been considerable effort directed at discovering novel anti-sickling reagents.Many of these have been designed to interact directly with HbS, to stabilise the oxy conformation (increasing O2 affinity) and to inhibit polymerisation